OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
OHGR57

One Health Group PLC

Healthcare Facilities & ServicesVerified

One Health Group PLC has a basic and diluted share count of 13,831,833 shares outstanding, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. The company's profitability and returns are not currently quantifiable due to the lack of disclosed financial metrics such as return on invested capital (ROIC) or operating margins. Without these, a direct comparison to industry benchmarks cannot be made. Segment and geographic exposure data are not available in the provided information, making it impossible to assess revenue concentration or geographic diversification. Growth trajectory is speculative, as no specific revenue history or outlook figures are provided. Analysts have assigned a mean price target of 300.33 GBP and a median price target of 300.00 GBP, with a mean recommendation of 1.33, indicating a generally positive outlook. The company's risk profile includes a low dilution potential, but liquidity risk remains unassessed. No specific risk factors or dilution sources are disclosed in the available documents. Recent events or filings that could impact the company's operations or financials are not detailed in the provided data.

30-day price · OHGR+10.64 (+4.5%)
Low$239.00High$252.00Close$248.50As of13 May, 00:00 UTC
Profile
CompanyOne Health Group PLC
TickerOHGR.L
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. One Health Group PLC operates in the healthcare facilities and services industry, providing biotechnology-related services and solutions.

Classification. The company is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Healthcare Facilities & Services industry with a confidence level of 0.92.

One Health Group PLC has a basic and diluted share count of 13,831,833 shares outstanding, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. The company's profitability and returns are not currently quantifiable due to the lack of disclosed financial metrics such as return on invested capital (ROIC) or operating margins. Without these, a direct comparison to industry benchmarks cannot be made. Segment and geographic exposure data are not available in the provided information, making it impossible to assess revenue concentration or geographic diversification. Growth trajectory is speculative, as no specific revenue history or outlook figures are provided. Analysts have assigned a mean price target of 300.33 GBP and a median price target of 300.00 GBP, with a mean recommendation of 1.33, indicating a generally positive outlook. The company's risk profile includes a low dilution potential, but liquidity risk remains unassessed. No specific risk factors or dilution sources are disclosed in the available documents. Recent events or filings that could impact the company's operations or financials are not detailed in the provided data.
Key takeaways
  • One Health Group PLC is classified in the Healthcare sector with a high confidence level.
  • The company has no immediate dilution pressure based on current share counts.
  • Analysts have a generally positive outlook, with a mean price target of 300.33 GBP.
  • Liquidity risk remains unassessed due to the lack of balance-sheet data.
  • No specific growth metrics or risk factors are disclosed in the available data.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$8.3M-$445.5k-$275.3k-$299.3k
FY-3$17.5M$1.4M$1.2M$434.8k
FY-2$20.5M$328.8k$60.3k-$553.6k
FY-1$23.0M$1.0M$707.9k-$111.9k
FY0$28.4M$1.5M$1.1M$360.3k
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$7.7M$4.0M
FY-3$10.8M$5.4M
FY-2$10.6M$5.7M
FY-1$11.1M$5.0M
FY0$18.6M$11.6M
PeriodOCFCapExFCFSBC
FY-4-$971.6k-$62.9k-$299.3k
FY-3$3.6M-$754.9k$434.8k
FY-2-$39.9k-$23.8k-$553.6k
FY-1$2.2M-$346.9k-$111.9k
FY0$1.7M-$264.2k$360.3k
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Biotechnology · cohort 117 companies
MetricOHGRActivity
Op margin5.6% medp25 -4.2% · p75 12.6%
Net margin2.8% medp25 -3.4% · p75 8.8%
Gross margin36.5% medp25 23.7% · p75 65.2%
CapEx / revenue-4.9% medp25 -11.5% · p75 -2.0%
Debt / equity69.3% medp25 7.9% · p75 120.9%
Observations
IR observations
Mean price target300.33 GBP
Median price target300.00 GBP
High price target313.00 GBP
Low price target288.00 GBP
Mean recommendation1.33 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.13 GBP
Mean revenue estimate30,227,000 GBP
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:08 UTC#fc159445
Market quoteclose GBP 249.50 · shares 0.01B diluted
no public URL
2026-05-12 01:08 UTC#c0a7bd03
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 20:24 UTCJob: d3f6fcc2